XTalks

NOVEMBER 2, 2023

Amgen’s Wezlana (ustekinumab-auub) has received US Food and Drug Administration (FDA) approval as a Stelara biosimilar for the treatment of several inflammatory diseases including Crohn’s disease, ulcerative colitis (UC), plaque psoriasis and psoriatic arthritis. This gives it a significant edge over a simple biosimilar designation.

FDA Approval 59

FDA Approval Production Dermatology Sales 59

XTalks

MAY 31, 2024

This novel combination antibiotic treatment is approved for complicated urinary tract infections (cUTIs), including pyelonephritis (a urinary tract infection when one or both kidneys become infected). Efficacy and Safety of Exblifep The FDA approved Exblifep based on clinical evidence that included the Phase III ALLIUM trial.

Bacteria 52

Bacteria FDA Approval Trials Pharma Companies 52

XTalks

AUGUST 18, 2020

“Providing this type of flexibility for processing saliva samples to test for COVID-19 infection is groundbreaking in terms of efficiency and avoiding shortages of crucial test components like reagents,” said FDA Commissioner Stephen M. Last month, the FDA approved a pooled test for COVID-19 developed by Quest Diagnostics.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. The global wearable medical devices market size was valued at $73.77

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

Drug Discovery World

APRIL 27, 2023

Megan Thomas takes a snapshot of the US biotech market and some of the ongoing research coming out of the US. In 2021, Savills put together a report on the regional hubs attracting science/pharma investment 1. The Boston Globe headline 3 , ‘Life sciences is poised to be Boston’s dominant industry.

Life Science 52

Life Science Drugs Research Gene Splicing 52

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. He has worked on Visensia, the world’s first FDA-approved multivariate patient monitoring system, and the SEND system, which is now used to monitor 20,000 patients each month in the NHS.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Engineer 96

XTalks

JUNE 25, 2024

In the past two years, the industry has faced considerable challenges due to a constrained financing environment, forcing many emerging and early-stage biotech companies to restructure their operations, merge with other companies or narrow their research and development (R&D) efforts by shelving certain assets. billion in 2023.

Pharma Companies 52

Pharma Companies Production FDA Approval Vaccination 52

XTalks

SEPTEMBER 28, 2023

While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharma companies. The ad vouches that Astepro provides allergy relief within 30 minutes.

Drugs 105

Drugs Allergies Branding FDA Approval 105

XTalks

FEBRUARY 21, 2024

Recently, Eli Lilly revealed promising results from a mid-stage trial, indicating that its popular drug, tirzepatide (marketed as Zepbound and Mounjaro for weight loss and diabetes, respectively), may be an effective treatment for the fatty liver disease metabolic dysfunction-associated steatohepatitis (MASH).

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

XTalks

MAY 29, 2024

The Financial Times’ list of the Americas’ Fastest Growing Companies 2024 provides an insight into the market’s leaders in terms of growth, highlighting not the size of companies but their capacity for innovation. The list features companies from all spheres such as IT, Marketing, Finance and more.

Medicine 52

Medicine Marketing FDA Approval Development 52

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccination Vaccine 98

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade.

Marketing 78

Marketing Gene Silencing Gene Drugs 78

XTalks

MAY 25, 2021

AbbVie (NYSE:ABBV) continues to face heat over complaints of patent exploitation and price hikes of its world’s best-selling drug Humira (adalimumab) to build a market monopoly and block out Humira biosimilar competition. According to the FDA, biosimilars are among the most rapidly growing class of therapeutic products in the US.

Production 98

Production Drugs Marketing Sales 98

Cloudbyz

MAY 19, 2021

Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. The gene therapy market reported its first market approvals back in 2017 and the evolution has been extensive ever since.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

pharmaphorum

AUGUST 31, 2021

For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. However, if history is any indication, pharma companies have been risk-averse when it comes to fully immersing itself into the expanded use of RWE in our development efforts.

Clinical Trials 70

Clinical Trials Clinical Trials Life Science Trials 70

Delveinsight

AUGUST 4, 2021

Several therapies have been approved in the Epilepsy Market. The Epilepsy Treatment Market is dominated by antiepileptic medications (AEDs), which is the early treatment choice for almost all patients with multiple seizures. In June 2021, Aducanumab by Biogen received FDA approval to treat patients with Alzheimer’s disease.

Marketing 98

Marketing Genetics Development Clinical Development 98

pharmaphorum

JULY 8, 2022

Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. Reites comments that “our partnership strategy is to align with companies that have an equal view of the market. Novel digital endpoints. About the author.

Clinical Trials 84

Clinical Trials Clinical Trials Trials Regulation 84

XTalks

NOVEMBER 9, 2023

The Alinity m high risk (HR) HPV assay is approved for HPV detection and use in routine cervical cancer screening as per professional medical guidelines, explained Abbott in a press release announcing the FDA approval.

FDA Approval 64

FDA Approval HR Genotype Life Science 64

Pharmaceutical Technology

FEBRUARY 13, 2023

While Xcopri is a treatment for only the more common epilepsies and not rare monogenetic ones, its approval was described as somewhat of a gamechanger, notes French. SK Life Science is a subsidiary of SK, a South Korean holding company. Epidiolex is approved for Dravet Syndrome, LGS, and tuberous sclerosis complex.

Research 264

Research Gene Gene Therapy Genome 264

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. Just last year, the FDA approved a one-time gene therapy treatment for hemophilia B priced at $3.5

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

MARCH 29, 2022

Jazz said the Kent Science Park site forms “the heart of our global cannabinoid manufacturing operations.”. Jazz Pharmaceuticals’ cannabidiol (CBD) drug Epidiolex became the first US Food and Drug Administration (FDA)-approved cannabis-based medication in 2018. Jazz is going green with its new facility in more than one way.

Medicine 111

Medicine Manufacturing Sales FDA Approval 111

XTalks

FEBRUARY 14, 2024

On the other hand, Republican senators largely defended the CEOs and the free market. They also blamed pharmacy benefit managers (PBMs), third-party companies that serve as pharma middlemen, who select which drugs receive insurance coverage and charge drug companies rebates and fees for covering them.

Drugs 52

Drugs Insulin Pharmacy Development 52